In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
MGI PHARMA signs exclusive license agreement
MGI Pharma and Helsinn expand Aloxi agreement
MGI PHARMA and SuperGen Announce Signing of a Worldwide License Agreement for Dacogen(TM)
AkaRx and MGI PHARMA Announce Closing of Development and License Agreement
MGI Pharma to acquire Guilford Pharmaceuticals
MGI PHARMA to Acquire Zycos; Pivotal Phase 3 Program for ZYC101a Planned for Early 2005
ALPHARMA AND MGI PHARMA ENTER INTO PROMOTION AGREEMENT FOR KADIAN® IN CANCER PAIN
Medicure acquires US rights to Aggrastat from MGI Pharma, Inc